Navigation Links
Czura Thornton Announces Intention to Acquire Global Central Laboratory Business of MDS Pharma Services
Date:10/9/2009

LONDON, Oct. 9 /PRNewswire/ -- Private investment firm Czura Thornton today announced it has signed an agreement to acquire the global central laboratory ('GCL') operations of MDS Pharma Services, a business unit of MDS Inc (NYSE: MDZ; TSX: MDS).

GCL, to announce a new brand shortly, provides a comprehensive range of late-stage laboratory and electrocardiogram services supporting clinical trials globally. The business' proprietary leading edge Apollo CLPM(TM) (Central Lab Protocol Management) system offers clients real-time access to study data from around the world. GCL employs 600 people at accredited facilities in Beijing, Hamburg, North Brunswick (New Jersey), Paris, Singapore and Toronto.

In a joint statement, Czura Thornton's founders Tony Czura and Nick Thornton said: "We are delighted to be acquiring MDS's global central laboratory platform and the deep expertise of the people there. Combined with our focus on the consistent delivery of high quality service and the flexibility and responsiveness that private ownership allows, we look forward to seeing renewed strength and growth in the business." They added that, "While we see excellent opportunities for collaboration with Chiltern, a leading CRO also owned by Czura Thornton, the two entities will operate independently."

The transaction is expected to close in the fourth quarter of 2009 and is subject to customary approvals and closing conditions. In addition, the sale of the Central Labs operations in France and Germany is subject to review and consultation with the applicable Works Councils in accordance with labor laws in those countries.

"We are pleased that the agreement with Czura Thornton creates opportunities to build the Central Labs business, which includes world-class facilities and highly skilled people focused on delivering superior client service," said Stephen P. DeFalco, President and Chief Executive Officer of MDS Inc.

About Czura Thornton: Czura Thornton is a private investment group that was founded by Tony Czura and Nick Thornton in 2003. The group, which owns leading CRO Chiltern (www.chiltern.com), has interests in the life sciences, international trade, property and automotive sectors. In particular Messrs Czura and Thornton have extensive international experience in the laboratory and CRO sectors. For further information see www.czurathornton.com.

Contact: Zareena Chattoo; +44 1753 216 611 (U.K.)

SOURCE Czura Thornton


'/>"/>
SOURCE Czura Thornton
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Genomic Health Announces Data Confirming Manual Microdissection of Biopsy Cavities Is Essential for Accurate Recurrence Risk Assessment in Early-Stage Breast Cancer Patients
2. Kimberly-Clark Announces Definitive Agreement to Acquire I-Flow Corporation
3. NIAID announces vaccine adjuvant discovery contracts
4. STEMCELL Technologies Inc. Announces Direct Distribution to Spain
5. ONRAD Announces New Partnership with La Maestra Community Health Centers of San Diego, CA
6. NCG Medical Announces Its Participation in Preliminary ARRA 2011 Certification Program
7. Institute for Liberty Announces the Launch of Keeping Small Business Healthy
8. PAREXEL Announces Date of First Quarter Fiscal Year 2010 Earnings Release and Conference Call
9. Medical Travel Company Satori World Medical Announces Relationship with Managing General Underwriter GreenWood International Insurance Services (GWI)
10. Cord Blood America Announces Debt Reduction Tally: $8.7 Million in 2009; $3.7 Million in Third Quarter
11. Tranziger Announces Formation of Global Advisory & Development Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s ... setting the bar too high can result in disappointment, perhaps even self-loathing. However, those ... goal. , Research from PsychTests.com reveals that behind the tendency to ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... New York, NY (PRWEB) , ... June 24, ... ... lifestyle publication Haute Living, is proud to recognize Dr. Barry M. Weintraub as ... believes that “the most beautiful women in the world, and the most handsome ...
(Date:6/24/2016)... ... ... Venture Construction Group (VCG) sponsors Luke’s Wings 5th Annual ... Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. The event raised funds ... been wounded in battle and their families. Venture Construction Group is a 2016 Silver ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Global MEMS Devices Medical Market Analysis 2016 - Forecast to ... The report contains up to date financial ... reliable analysis. Assessment of major trends with potential impact on ... dive analysis of market segmentation which comprises of sub markets, ...
(Date:6/23/2016)... 2016 Bracket , a leading clinical trial ... clinical outcomes platform, Bracket eCOA (SM) 6.0, at the ... – 30, 2016 in Philadelphia , Pennsylvania.  ... Assessment product of its kind to fully integrate with RTSM, ... eCOA 6.0 is a flexible platform for electronic clinical outcomes ...
Breaking Medicine Technology: